About the Study

Chronic Kidney Disease (CKD) and Proteinuria: A study on finerenone treatment for CKD and proteinuria

A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to <18 years of age, with chronic kidney disease and proteinuria.

Interested in learning more?

Full Study Name: FIONA – Finerenone for the treatment of children with CKD and proteinuria